PI
Putnam Investments Portfolio holdings
AUM
$75.7B
1-Year Return
34.47%
This Quarter Return
+13.42%
1 Year Return
+34.47%
3 Year Return
+62.08%
5 Year Return
+203.67%
10 Year Return
+403.53%
AUM
$75.7B
AUM Growth
+$9.96B
(+15%)
Cap. Flow
+$1.95B
Cap. Flow
% of AUM
2.58%
Top 10 Holdings %
Top 10 Hldgs %
25.53%
Holding
1,266
New
131
Increased
416
Reduced
568
Closed
116
Top Buys
| 1 |
CRH
CRH
|
+$456M |
| 2 |
Boston Scientific
BSX
|
+$397M |
| 3 |
Humana
HUM
|
+$339M |
| 4 |
T-Mobile US
TMUS
|
+$270M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$203M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
+$479M |
| 2 |
Abbott
ABT
|
+$409M |
| 3 |
Elevance Health
ELV
|
+$395M |
| 4 |
Danaher
DHR
|
+$385M |
| 5 |
Intuit
INTU
|
+$256M |
Sector Composition
| 1 | Technology | 24.54% |
| 2 | Healthcare | 14.61% |
| 3 | Financials | 12.81% |
| 4 | Consumer Discretionary | 10.55% |
| 5 | Industrials | 8.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
926
Vir Biotechnology
VIR
$728M
| $393K | ﹤0.01% |
+39,093
| New | +$393K |
|
927
Jakks Pacific
JAKK
$195M
| $393K | ﹤0.01% |
+11,059
| New | +$393K |
|
928
Ligand Pharmaceuticals
LGND
$3.22B
| $393K | ﹤0.01% |
5,503
-144
| -3% | -$10.3K |
|
929
EnerSys
ENS
$3.89B
| $393K | ﹤0.01% |
+3,888
| New | +$393K |
|
930
United Natural Foods
UNFI
$1.74B
| $392K | ﹤0.01% |
24,177
+4,393
| +22% | +$71.3K |
|
931
Gentherm
THRM
$1.09B
| $392K | ﹤0.01% |
7,479
+1,319
| +21% | +$69.1K |
|
932
Gibraltar Industries
ROCK
$1.74B
| $391K | ﹤0.01% |
+4,955
| New | +$391K |
|
933
SITE Centers
SITC
$476M
| $391K | ﹤0.01% |
36,785
-1,156
| -3% | -$12.3K |
|
934
DMC Global
BOOM
$147M
| $391K | ﹤0.01% |
20,779
+7,157
| +53% | +$135K |
|
935
Adaptive Biotechnologies
ADPT
$1.92B
| $390K | ﹤0.01% |
79,596
-113,897
| -59% | -$558K |
|
936
WesBanco
WSBC
$3.03B
| $389K | ﹤0.01% |
12,411
-6,678
| -35% | -$209K |
|
937
Adient
ADNT
$1.95B
| $387K | ﹤0.01% |
10,648
+732
| +7% | +$26.6K |
|
|
SHYF
938
DELISTED
The Shyft Group
SHYF
| $387K | ﹤0.01% |
31,645
+8,300
| +36% | +$101K |
|
|
AGS
939
DELISTED
PlayAGS
AGS
| $387K | ﹤0.01% |
45,860
+8,045
| +21% | +$67.8K |
|
940
Ambarella
AMBA
$3.61B
| $386K | ﹤0.01% |
6,304
+447
| +8% | +$27.4K |
|
941
Surmodics
SRDX
$470M
| $386K | ﹤0.01% |
10,628
-1,361
| -11% | -$49.5K |
|
942
First Financial Corporation Common Stock
THFF
$691M
| $386K | ﹤0.01% |
8,977
-274
| -3% | -$11.8K |
|
|
TRTX
943
TPG RE Finance Trust
TRTX
$747M
| $386K | ﹤0.01% |
59,421
+4,180
| +8% | +$27.2K |
|
944
Usana Health Sciences
USNA
$555M
| $386K | ﹤0.01% |
7,194
+528
| +8% | +$28.3K |
|
945
Oneok
OKE
$45.2B
| $385K | ﹤0.01% |
5,489
-434
| -7% | -$30.5K |
|
946
AngioDynamics
ANGO
$447M
| $384K | ﹤0.01% |
49,027
-1,549
| -3% | -$12.1K |
|
947
Addus HomeCare
ADUS
$2.08B
| $384K | ﹤0.01% |
4,139
-121
| -3% | -$11.2K |
|
948
Abercrombie & Fitch
ANF
$4.48B
| $383K | ﹤0.01% |
+4,338
| New | +$383K |
|
|
ITOS
949
DELISTED
iTeos Therapeutics
ITOS
| $382K | ﹤0.01% |
+34,904
| New | +$382K |
|
950
L3Harris
LHX
$50.6B
| $382K | ﹤0.01% |
1,813
-18,258
| -91% | -$3.85M |
|